| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.21 | 0.004 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.005 |